LPL Financial
INMB icon

LPL Financial’s INmune Bio INMB Stock Holding History

LPL Financial’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-43,172
Closed -$99.7K – 5893
2025
Q2 		$99.7K Buy
+43,172
New +$317K ﹤0.01% 5267
2025
Q1 		– Sell
-19,072
Closed -$89.1K – 5441
2024
Q4 		$89.1K Buy
19,072
+4,730
+33% +$24.7K ﹤0.01% 5014
2024
Q3 		$77.3K Buy
14,342
+945
+7% +$6.72K ﹤0.01% 4942
2024
Q2 		$118K Buy
13,397
+3,375
+34% +$33.3K ﹤0.01% 4705
2024
Q1 		$118K Sell
10,022
-75
-0.7% -$906 ﹤0.01% 4644
2023
Q4 		$114K Hold
10,097
– – ﹤0.01% 4526
2023
Q3 		$68.4K Buy
+10,097
New +$83.7K ﹤0.01% 4479

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial's INMB Position: Q3 2025 in Review

LPL Financial sold out of INmune Bio (INMB) in Q3 2025, closing a stake of 43,172 shares — an estimated $99.7K sold.

LPL Financial first reported a position in INMB in Q3 2023 and held it in 7 quarters. The position peaked at $118K in Q2 2024. 73 funds tracked by Wall St. Rank hold INMB as of Q3 2025.

  • LPL Financial reported no remaining INmune Bio position as of Q3 2025 after selling out during the quarter.
  • LPL Financial sold 43,172 INmune Bio shares in Q3 2025, an estimated $99.7K.
  • LPL Financial first reported a position in INmune Bio in Q3 2023 and held it in 7 quarters.
  • LPL Financial's INmune Bio position peaked at $118K in Q2 2024.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q3 2025.

Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.